Andra språk Microsoft Corporation

Aktier

MSFT

US5949181045

Programvara

Realtidsuppskattning Cboe BZX Andra börsplatser 17.52.41 2026-04-14			5-dagars förändring	Förändring 1 jan.
393,70 ^USD	+2,43 %		+5,41 %	−18,86 %

17.51	Novo Nordisk A/S och OpenAI i partnerskap för att transformera läkemedelsutveckling och leverans	CI
17.02	Wells Fargos VD: Ekonomisk påverkan sannolik, men risker balanseras av mildrande faktorer; svårt att förutse den slutgiltiga effekten	RE

Andra språk

17.51	Novo Nordisk A/S and OpenAI Partner to Transform How Medicines Are Discovered and Delivered
17.02	Wells Fargo CEO: There will likely be some economic impact, but there are both risks and potential mitigants; hard to predict the ultimate impact
15.52	Exchange-Traded Funds, Equity Futures Lower Pre-Bell Tuesday Amid Hopes of Long-Term US-Iran Truce
15.42	S&P 500 Rebound, Optimism for US-Iran Deal Move US Equity Futures Higher Pre-Bell
15.39	Microsoft Developing New Features for Copilot Inspired by OpenClaw
15.34	Auf Entspannung setzen
15.25	Una apuesta por la moderación
15.07	Betting on Restraint
12.46	Social Buzz: Wallstreetbets Stocks Advance Premarket Tuesday; Nebius, Micron to Rise
12.26	Wegovy Maker Novo Nordisk Strikes Deal With OpenAI to Speed Up Drug Discovery -- Update
12.21	OpenAI to Acquire AI Financial Planner Hiro
11.59	Microsoft-Backed OpenAI Strategy Shift Raises Investor Concerns Amid Rising Competition
11.54	AI botst op de elektrische muur: drie winnaars die daarvan profiteren
11.46	Pharma sector doubles down on AI amid hopes of slashing costs, timelines
11.37	Microsoft Exec Says Carbon Removal Program 'Has Not Ended'
11.14	European Midday Briefing : Shares Rise, Oil Slips on Peace Talks Hopes
10.34	Novo Nordisk, Microsoft-backed OpenAI Partner to Accelerate Drug Development With AI Integration
10.12	Asian markets firm on hopes of Middle East war resolution
09.26	FT: Investoren zweifeln an Bewertung von OpenAI - Fehlende Strategie
09.03	Novo Nordisk und OpenAI kooperieren in der Medikamententwicklung
08.46	Novo Nordisk and OpenAI Partner to Speed Drug Discovery
08.41	Novo Nordisk Partners with OpenAI to Boost Drug Development, Delivery
08.01	Wegovy-maker Novo Nordisk partners with OpenAI to speed drug development
07.55	Inversores cuestionan valoración y estrategia de OpenAI ante la competencia, según el FT
06.49	Asian equities, FX firm as optimism seeps in over US-Iran talks